Patents by Inventor Edgar Ong

Edgar Ong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Kits for detecting nucleic acid
    Patent number: 11802317
    Abstract: Disclosed is a method for determining the presence of Mycobacterium avium complex nucleic acids in a biological sample. In particular, the mig gene of M. avium and the DT1 gene of M. intracellulare are detected, preferably following amplification. In addition, the method distinguishes between species of M. avium and M. intracellulare. Also described are oligonucleotides that can be used as primers to amplify target genes such as mig and DT1 genes and as probes as well as kits containing the oligonucleotide.
    Type: Grant
    Filed: December 23, 2020
    Date of Patent: October 31, 2023
    Assignee: Quest Diagnostics Investments LLC
    Inventors: Edgar Ong, Maurice Exner
  • KITS FOR DETECTING MYCOBACTERIUM AVIUM/INTRACELLULARE NUCLEIC ACID
    Publication number: 20210222232
    Abstract: Disclosed is a method for determining the presence of Mycobacterium avium complex nucleic acids in a biological sample. In particular, the mig gene of M. avium and the DT1 gene of M. intracellulare are detected, preferably following amplification. In addition, the method distinguishes between species of M. avium and M. intracellulare.
    Type: Application
    Filed: December 23, 2020
    Publication date: July 22, 2021
    Applicant: Quest Diagnostics Investments LLC
    Inventors: Edgar ONG, Maurice EXNER
  • Kits for detecting nucleic acid
    Patent number: 10876175
    Abstract: Disclosed is a method for determining the presence of Mycobacterium avium complex nucleic acids in a biological sample. In particular, the mig gene of M. avium and the DT1 gene of M. intracellulare are detected, preferably following amplification. In addition, the method distinguishes between species of M. avium and M. intracellulare. Also described are oligonucleotides that can be used as primers to amplify target genes such as mig and DT1 genes and as probes as well as kits containing the oligonucleotide.
    Type: Grant
    Filed: October 23, 2017
    Date of Patent: December 29, 2020
    Assignee: Quest Diagnostics Investments Incorporated
    Inventors: Edgar Ong, Maurice Exner
  • KITS FOR DETECTING MYCOBACTERIUM AVIUM/INTRACELLULARE NUCLEIC ACID
    Publication number: 20180037938
    Abstract: Disclosed is a method for determining the presence of Mycobacterium avium complex nucleic acids in a biological sample. In particular, the mig gene of M. avium and the DT1 gene of M. intracellulare are detected, preferably following amplification. In addition, the method distinguishes between species of M. avium and M. intracellulare.
    Type: Application
    Filed: October 23, 2017
    Publication date: February 8, 2018
    Applicant: Quest Diagnostics Investments Incorporated
    Inventors: Edgar ONG, Maurice Exner
  • Kits for detecting /intracellulare nucleic acid
    Patent number: 9797018
    Abstract: Disclosed is a method for determining the presence of Mycobacterium avium complex nucleic acids in a biological sample. In particular, the mig gene of M. avium and the DT1 gene of M. intracellulare are detected, preferably following amplification. In addition, the method distinguishes between species of M. avium and M. intracellulare. Also described are oligonucleotides that can be used as primers to amplify target genes such as mig and DT1 genes and as probes as well as kits containing the oligonucleotide.
    Type: Grant
    Filed: November 14, 2011
    Date of Patent: October 24, 2017
    Assignee: Quest Diagnostics Investments Incorporated
    Inventors: Edgar Ong, Maurice Exner
  • ASSAY FOR MYCOBACTERIUM AVIUM/INTRACELLULARE NUCLEIC ACID
    Publication number: 20120088242
    Abstract: Disclosed is a method for determining the presence of Mycobacterium avium complex nucleic acids in a biological sample. In particular, the mig gene of M. avium and the DT1 gene of M. intracellulare are detected, preferably following amplification. In addition, the method distinguishes between species of M. avium and M. intracellulare.
    Type: Application
    Filed: November 14, 2011
    Publication date: April 12, 2012
    Inventors: Edgar Ong, Maurice Exner
  • Assay for nucleic acid
    Patent number: 8084212
    Abstract: Disclosed is a method for determining the presence of Mycobacterium avium complex nucleic acids in a biological sample. In particular, the IS1245 gene of M. avium and the DT1 gene of M. intracellulare are detected, preferably following amplification. In addition, the method distinguishes between species of M. avium and M. intracellulare. Also described are oligonucleotides that can be used as primers to amplify target genes such as IS1245 and DT1 genes and as probes as well as kits containing the oligonucleotides.
    Type: Grant
    Filed: September 21, 2010
    Date of Patent: December 27, 2011
    Assignee: Quest Diagnostics Investments Incorporated
    Inventors: Edgar Ong, Maurice Exner
  • ASSAY FOR MYCOBACTERIUM AVIUM/INTRACELLULARE NUCLEIC ACID
    Publication number: 20110027792
    Abstract: Disclosed is a method for determining the presence of Mycobacterium avium complex nucleic acids in a biological sample. In particular, the mig gene of M. avium and the DT1 gene of M. intracellulare are detected, preferably following amplification. In addition, the method distinguishes between species of M. avium and M. intracellulare. Also described are oligonucleotides that can be used as primers to amplify target genes such as mig and DT1 genes and as probes as well as kits containing the oligonucleotides.
    Type: Application
    Filed: September 21, 2010
    Publication date: February 3, 2011
    Inventors: Edgar Ong, Maurice Exner
  • Assay for nucleic acid
    Patent number: 7824858
    Abstract: Disclosed is a method for determining the presence of Mycobacterium avium complex nucleic acids in a biological sample. In particular, the mig gene of M. avium and the DT1 gene of M. intracellulare are detected, preferably following amplification. In addition, the method distinguishes between species of M. avium and M. intracellulare. Also described are oligonucleotides that can be used as primers to amplify target genes such as mig and DT1 genes and as probes as well as kits containing the oligonucleotides.
    Type: Grant
    Filed: January 23, 2006
    Date of Patent: November 2, 2010
    Assignee: Quest Diagnostics Investments Incorporated
    Inventors: Edgar Ong, Maurice Exner
  • Assay for mycobacterium avium/intracellulare nucleic acid
    Publication number: 20070172838
    Abstract: Disclosed is a method for determining the presence of Mycobacterium avium complex nucleic acids in a biological sample. In particular, the mig gene of M avium and the DT1 gene of M. intracellulare are detected, preferably following amplification. In addition, the method distinguishes between species of M avium and M intracellulare. Also described are oligonucleotides that can be used as primers to amplify target genes such as mig and DT1 genes and as probes as well as kits containing the oligonucleotides.
    Type: Application
    Filed: January 23, 2006
    Publication date: July 26, 2007
    Inventors: Edgar Ong, Maurice Exner
  • Nucleic acid molecules encoding serine protease 16, the encoded polypeptides and methods based thereon
    Publication number: 20050112579
    Abstract: Provided herein are serine proteases designated CVSP16. CVSP16 polypeptides exhibit protease activity as a single chain or as a multi-chain form. Methods using the polypeptides to identify compounds that modulate the protease activity thereof are provided. The polypeptides also serve as tumor markers.
    Type: Application
    Filed: July 1, 2003
    Publication date: May 26, 2005
    Applicant: DENDREON SAN DIEGO LLC, a Delaware corporation
    Inventors: Edwin Madison, Edgar Ong, Jiunn- Chern Yeh
  • Sulfotransferase for HNK-1 glycan
    Patent number: 6323332
    Abstract: Sulfotransferases that synthesize the HNK-1 carbohydrate epitope by adding a sulfate group to GlcA&bgr;1→3Gal&bgr;1→4GlcNAc&bgr;1→R to form glycan sulfo→3GlcA&bgr;1→3Gal&bgr;1→4GlcNAc&bgr;1→R. They are exemplified by human (hu-HNK-1ST) and mouse (mHNK-1ST) sulfotransferases. Also provided are related peptides, antibodies, nucleic acids and methods.
    Type: Grant
    Filed: January 21, 1999
    Date of Patent: November 27, 2001
    Assignee: The Burnham Institute
    Inventors: Minoru Fukuda, Edgar Ong